MS
ARRY

Maven Securities’s Array Biopharma Inc ARRY Stock Holding History

Maven Securities’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-61,000
Closed -$2.82M – 241
2019
Q2 		$2.82M Buy
+61,000
New +$1.71M 1.88% 20

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Maven Securities's ARRY Position: Q3 2019 in Review

Maven Securities sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 61,000 shares — an estimated $2.82M sold.

Maven Securities first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $2.82M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Maven Securities reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Maven Securities sold 61,000 Array Biopharma Inc shares in Q3 2019, an estimated $2.82M.
  • Maven Securities first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Maven Securities's Array Biopharma Inc position peaked at $2.82M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Maven Securities's 13F filing for Q3 2019, filed 14 Nov 2019.